Skip to main content

Advertisement

ADVERTISEMENT

BHE News, Insights, Podcasts, and More

News
12/11/2021
Deni Carise, PhD, chief science officer for Recovery Centers of America, who participated in a panel on metrics-driven growth on Saturday at TCIV, discussed how organizations can cut through noise and identify their most useful data points.
Deni Carise, PhD, chief science officer for Recovery Centers of America, who participated in a panel on metrics-driven growth on Saturday at TCIV, discussed how organizations can cut through noise and identify their most useful data points.
Deni Carise, PhD, chief science...
12/11/2021
Behavioral Healthcare Executive
News
12/10/2021
As demand for services rises and money pours into the field, behavioral healthcare providers need to stick to good principles and keep the needs of patients top of mind, Zac Clark, co-founder of Release Recovery, told TCIV attendees in a...
As demand for services rises and money pours into the field, behavioral healthcare providers need to stick to good principles and keep the needs of patients top of mind, Zac Clark, co-founder of Release Recovery, told TCIV attendees in a...
As demand for services rises and...
12/10/2021
Behavioral Healthcare Executive
News
12/10/2021
A confluence of factors has made behavioral healthcare attractive to investors, Dexter Braff, MBA, MS, president of the Braff Group, told Treatment Center Investment & Valuation Retreat attendees on Friday in Scottsdale, Arizona.
A confluence of factors has made behavioral healthcare attractive to investors, Dexter Braff, MBA, MS, president of the Braff Group, told Treatment Center Investment & Valuation Retreat attendees on Friday in Scottsdale, Arizona.
A confluence of factors has made...
12/10/2021
Behavioral Healthcare Executive
News
12/09/2021
Cybin has received approval for a Phase 2 trial to evaluate psychedelic-assisted psychotherapy with psilocybin for frontline clinicians experiencing COVID-related distress, Novamind has opened an addiction treatment clinic in Utah, and...
Cybin has received approval for a Phase 2 trial to evaluate psychedelic-assisted psychotherapy with psilocybin for frontline clinicians experiencing COVID-related distress, Novamind has opened an addiction treatment clinic in Utah, and...
Cybin has received approval for...
12/09/2021
Behavioral Healthcare Executive
Ron Manderscheid, PhD
Perspectives
12/09/2021
Our county, state, and federal public health programs have worked valiantly during the COVID-19 pandemic, but our failure to achieve a coordinated national action has been a foundational problem.
Our county, state, and federal public health programs have worked valiantly during the COVID-19 pandemic, but our failure to achieve a coordinated national action has been a foundational problem.
Our county, state, and federal...
12/09/2021
Behavioral Healthcare Executive
News
12/08/2021
Mindpath has acquired 4 Ohio outpatient clinics from Vertava, while Acadia and Orlando Health have announced a joint venture, Voyages is adding a 2nd behavioral health program in Texas.
Mindpath has acquired 4 Ohio outpatient clinics from Vertava, while Acadia and Orlando Health have announced a joint venture, Voyages is adding a 2nd behavioral health program in Texas.
Mindpath has acquired 4 Ohio...
12/08/2021
Behavioral Healthcare Executive
Clark Lagemann
Perspectives
12/06/2021
While patient engagement programs will always face challenges, combining the benefits of in-person and virtual patient engagement programs can lead to greater access to care and increase a patient’s long-term recovery.
While patient engagement programs will always face challenges, combining the benefits of in-person and virtual patient engagement programs can lead to greater access to care and increase a patient’s long-term recovery.
While patient engagement...
12/06/2021
Behavioral Healthcare Executive
Ed Jones, PhD
Perspectives
12/06/2021
History has shown us that medical and psychosocial frameworks understand problems in different ways. Each offers both pros and cons, and both should be considered when identifying what’s best for a patient’s care.
History has shown us that medical and psychosocial frameworks understand problems in different ways. Each offers both pros and cons, and both should be considered when identifying what’s best for a patient’s care.
History has shown us that...
12/06/2021
Behavioral Healthcare Executive
News
12/03/2021
Pear Therapeutics has received Breakthrough Device Designation from FDA for a prescription digital therapeutic candidate for alcohol use disorder. Banyan is adding an eating disorder program. Verinetics has received a NIDA grant to develop a...
Pear Therapeutics has received Breakthrough Device Designation from FDA for a prescription digital therapeutic candidate for alcohol use disorder. Banyan is adding an eating disorder program. Verinetics has received a NIDA grant to develop a...
Pear Therapeutics has received...
12/03/2021
Behavioral Healthcare Executive
News
12/01/2021
Donald J. Hevey was a key voice in the development of not-for-profit Community Mental Health Centers and the first leader of Mental Health Corporations of America.
Donald J. Hevey was a key voice in the development of not-for-profit Community Mental Health Centers and the first leader of Mental Health Corporations of America.
Donald J. Hevey was a key voice...
12/01/2021
Behavioral Healthcare Executive

Advertisement

Advertisement

Advertisement